LCP
PCRX icon

Legacy Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$3.15M Sell
41,252
-200
-0.5% -$15.3K 1.04% 30
2021
Q4
$2.49M Sell
41,452
-228
-0.5% -$13.7K 0.81% 40
2021
Q3
$2.33M Sell
41,680
-71
-0.2% -$3.98K 0.84% 40
2021
Q2
$2.53M Sell
41,751
-200
-0.5% -$12.1K 0.91% 35
2021
Q1
$2.94M Hold
41,951
1.11% 28
2020
Q4
$2.51M Sell
41,951
-1,400
-3% -$83.8K 0.98% 32
2020
Q3
$2.61M Sell
43,351
-200
-0.5% -$12K 1.05% 33
2020
Q2
$2.29M Sell
43,551
-130
-0.3% -$6.82K 0.98% 36
2020
Q1
$1.47M Sell
43,681
-164
-0.4% -$5.5K 0.73% 43
2019
Q4
$1.99M Sell
43,845
-700
-2% -$31.7K 0.8% 44
2019
Q3
$1.7M Sell
44,545
-4,028
-8% -$153K 0.74% 46
2019
Q2
$2.11M Buy
48,573
+1,025
+2% +$44.6K 0.94% 42
2019
Q1
$1.81M Sell
47,548
-460
-1% -$17.5K 0.84% 43
2018
Q4
$2.07M Buy
48,008
+475
+1% +$20.4K 1.09% 36
2018
Q3
$2.34M Sell
47,533
-1,055
-2% -$51.8K 1.08% 35
2018
Q2
$1.56M Sell
48,588
-800
-2% -$25.6K 0.76% 49
2018
Q1
$1.54M Sell
49,388
-1,105
-2% -$34.4K 0.77% 49
2017
Q4
$2.31M Buy
50,493
+3,100
+7% +$142K 1.14% 38
2017
Q3
$1.78M Buy
47,393
+600
+1% +$22.5K 0.94% 43
2017
Q2
$2.23M Buy
46,793
+3,045
+7% +$145K 1.21% 33
2017
Q1
$2M Buy
43,748
+3,695
+9% +$169K 1.12% 38
2016
Q4
$1.29M Buy
40,053
+223
+0.6% +$7.21K 0.78% 47
2016
Q3
$1.36M Buy
39,830
+16,630
+72% +$569K 0.86% 43
2016
Q2
$783K Buy
23,200
+100
+0.4% +$3.38K 0.49% 61
2016
Q1
$1.22M Buy
23,100
+3,050
+15% +$162K 0.79% 46
2015
Q4
$1.54M Sell
20,050
-600
-3% -$46.1K 0.99% 37
2015
Q3
$849K Buy
+20,650
New +$849K 0.58% 59